Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous stem cell transplantation in refractory Crohn's disease
NL-OMON39547Recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jun 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous hematopoietic stem cells in Crohn's disease and inflammatory bowel disease (IBD), sponsored by St. Antonius Ziekenhuis. Started Jun 2014; status: recruiting.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
Crohn's diseaseinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON39547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39547.